Covid-19 manufacturing roundup: WHO letter outlines reboot of IP sharing program; India backs down on domestically-produced vaccine trial
While vaccine shortages have kept many countries in the midst of the pandemic, the World Health Organization is rebooting its IP sharing scheme.
The Costa Rican president Alvarado Quesada and Director General of the WHO Tedros Adhanom Ghebreysus released a letter Thursday calling for the revamping of the Solidarity Call to Action plan that was outlined a year ago.
“The single most important priority of the global community is to stop the COVID-19 pandemic in its tracks, to halt its rapid transmission and reverse the trend of consequential global distress,” the letter says. “We know that this goal is only achievable when everyone, everywhere can access the health technologies they need for COVID-19 detection, prevention, treatment and response.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.